Acurx Pharmaceuticals, Inc.

Nasdaq:ACXP

Pharmaceutical Preparations·STATEN ISLAND, NY

CEO

Luci David P

CFO

Shawah Robert G.

Financials

18 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/11/25	→
10-Q	Q1 2025	3/31/25	5/12/25	→
10-K	FY 2024	12/31/24	3/17/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
10-Q	Q2 2024	6/30/24	8/8/24	→
↓

Earnings Releases (8-K)

16 shown

Filed	Period
5/13/25	Q2 FY2025	→
3/18/25	Q1 FY2025	→
11/13/24	Q4 FY2024	→
8/9/24	Q3 FY2024	→
5/15/24	Q2 FY2024	→
3/18/24	Q1 FY2024	→
↓

News (8-K)

19 shown

Filed	Type	Description
3/9/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
9/22/25	Other	Amendments to Articles of Incorporation or Bylaws	→
9/19/25	Vote	Submission of Matters to a Vote of Security Holders	→
7/31/25	Other	Material Modification to Rights of Security Holders	→
7/17/25	Vote	Submission of Matters to a Vote of Security Holders	→
6/20/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

38 shown

Filed	Form	Description
2/11/26	424B3	424B3	→
2/2/26	S-1	S-1	→
12/30/25	S-3/A	FORM S-3/A	→
11/10/25	424B3	424B3	→
10/20/25	S-1	S-1	→
7/15/25	S-1	S-1	→
↓

Filing History(208 filings)

TypeDateAccessionPeriodSize

8-K

Mar 9, 2026

0001104659-26-025003FORM 8-K

Mar 9, 2026

243.0 KB

EFFECT

Feb 11, 2026

9999999995-26-000533

—

1.8 KB

424B3

Feb 11, 2026

0001104659-26-013390424B3

—

287.2 KB

S-1

Feb 2, 2026

0001104659-26-009266S-1

—

642.8 KB

EFFECT

Jan 6, 2026

9999999995-26-000076

—

1.8 KB

S-3/A

Dec 30, 2025

0001104659-25-125201FORM S-3/A

—

340.4 KB

SCHEDULE 13G/A

Nov 14, 2025

0001172661-25-005168

—

10.4 KB

10-Q

Nov 12, 2025

0001104659-25-10969810-Q

Sep 30, 2025

5.7 MB

424B3

Nov 10, 2025

0001104659-25-109289424B3

—

236.7 KB

S-1

Oct 20, 2025

0001104659-25-100800FORM S-1

—

551.3 KB

8-K

Sep 22, 2025

0001104659-25-092166FORM 8-K

Sep 22, 2025

199.6 KB

8-K

Sep 19, 2025

0001104659-25-091733FORM 8-K

Sep 16, 2025

192.1 KB

SCHEDULE 13G

Aug 14, 2025

0001172661-25-003563

—

10.2 KB

10-Q

Aug 11, 2025

0001558370-25-01104510-Q

Jun 30, 2025

5.4 MB

DEFA14A

Aug 5, 2025

0001104659-25-073997DEFA14A

—

375.7 KB

DEF 14A

Aug 4, 2025

0001104659-25-073623DEF 14A

Sep 16, 2025

756.2 KB

8-K

Jul 31, 2025

0001104659-25-072529FORM 8-K

Jul 31, 2025

220.1 KB

PRE 14A

Jul 24, 2025

0001104659-25-070373PRE 14A

Sep 16, 2025

754.5 KB

EFFECT

Jul 23, 2025

9999999995-25-002331

—

1.8 KB

CORRESP

Jul 21, 2025

0001104659-25-069322

—

7.8 KB

UPLOAD

Jul 21, 2025

0000000000-25-007662

—

39.2 KB

8-K

Jul 17, 2025

0001104659-25-068659FORM 8-K

Jul 17, 2025

201.8 KB

S-1

Jul 15, 2025

0001104659-25-067841FORM S-1

—

336.5 KB

S-3

Jul 9, 2025

0001104659-25-066693FORM S-3

—

1.3 MB

Jun 27, 2025

0001104659-25-063623

—

12.3 KB

25 filings shown

Filed	Form	Description
2/6/25	4	OWNERSHIP DOCUMENT	→
2/6/25	4	OWNERSHIP DOCUMENT	→
2/6/25	4	OWNERSHIP DOCUMENT	→
1/8/25	4	OWNERSHIP DOCUMENT	→
1/8/25	4	OWNERSHIP DOCUMENT	→
1/8/25	4	OWNERSHIP DOCUMENT	→
↓

Acurx Pharmaceuticals, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(208 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
8/5/25	DEFA14A	DEFA14A	→
8/4/25	DEF 14A	DEF 14A	→
7/24/25	PRE 14A	PRE 14A	→
5/29/25	DEFA14A	DEFA14A	→
5/29/25	DEF 14A	DEF 14A	→
5/19/25	PRE 14A	PRE 14A	→
↓